Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paola Secchiero

Showing results (1-10 of 212) with videos related to

Pageof 22
Sort By:
Cytokine & Growth Factor Reviews|June 6, 2006
The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biologyGiorgio Zauli, Paola Secchiero
Current Opinion in Hematology|November 29, 2007
Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesisPaola Secchiero, Giorgio Zauli
Expert Opinion on Therapeutic Targets|May 10, 2011
Molecular targets for selective killing of TRAIL-resistant leukemic cellsGiorgio Zauli, Raffaella Bosco, Paola Secchiero
Recent Patents on Anti-Cancer Drug Discovery|November 26, 2011
State of art and recent developments of anti-cancer strategies based on TRAILStella Bernardi, Paola Secchiero, Giorgio Zauli
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
TRAIL and osteoprotegerin: a role in endothelial physiopathology?Federica Corallini, Erika Rimondi, Paola Secchiero
International Journal of Molecular Sciences|September 10, 2021
Purinergic Signaling and Inflammasome Activation in Psoriasis PathogenesisDavide Ferrari, Fabio Casciano, Paola Secchiero, et al.
Current Pharmaceutical Design|March 12, 2011
Recent advances in the therapeutic perspectives of Nutlin-3Paola Secchiero, Raffaella Bosco, Claudio Celeghini, et al.
Molecular Carcinogenesis|November 30, 2012
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3Rebecca Voltan, Paola Secchiero, Federica Corallini, et al.
Cytokine|June 26, 2012
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharideAnnalisa Marcuzzi, Paola Secchiero, Sergio Crovella, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 13, 2003
IFN-alpha2b increases interleukin-10 expression in primary activated human CD8+ T cellsSabrina Curreli, Fabio Romerio, Paola Secchiero, et al.
Pageof 22

Showing results (1-10 of 212) with videos related to

Sort By:
Pageof 22
Cytokine & Growth Factor Reviews|June 6, 2006
The role of the TRAIL/TRAIL receptors system in hematopoiesis and endothelial cell biologyGiorgio Zauli, Paola Secchiero
Current Opinion in Hematology|November 29, 2007
Tumor-necrosis-factor-related apoptosis-inducing ligand and the regulation of hematopoiesisPaola Secchiero, Giorgio Zauli
Expert Opinion on Therapeutic Targets|May 10, 2011
Molecular targets for selective killing of TRAIL-resistant leukemic cellsGiorgio Zauli, Raffaella Bosco, Paola Secchiero
Recent Patents on Anti-Cancer Drug Discovery|November 26, 2011
State of art and recent developments of anti-cancer strategies based on TRAILStella Bernardi, Paola Secchiero, Giorgio Zauli
Frontiers in Bioscience : a Journal and Virtual Library|November 6, 2007
TRAIL and osteoprotegerin: a role in endothelial physiopathology?Federica Corallini, Erika Rimondi, Paola Secchiero
International Journal of Molecular Sciences|September 10, 2021
Purinergic Signaling and Inflammasome Activation in Psoriasis PathogenesisDavide Ferrari, Fabio Casciano, Paola Secchiero, et al.
Current Pharmaceutical Design|March 12, 2011
Recent advances in the therapeutic perspectives of Nutlin-3Paola Secchiero, Raffaella Bosco, Claudio Celeghini, et al.
Molecular Carcinogenesis|November 30, 2012
Selective induction of TP53I3/p53-inducible gene 3 (PIG3) in myeloid leukemic cells, but not in normal cells, by Nutlin-3Rebecca Voltan, Paola Secchiero, Federica Corallini, et al.
Cytokine|June 26, 2012
TRAIL administration down-modulated the acute systemic inflammatory response induced in a mouse model by muramyldipeptide or lipopolysaccharideAnnalisa Marcuzzi, Paola Secchiero, Sergio Crovella, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|February 13, 2003
IFN-alpha2b increases interleukin-10 expression in primary activated human CD8+ T cellsSabrina Curreli, Fabio Romerio, Paola Secchiero, et al.
Pageof 22